Oregon Health And Science University
Clinical trials sponsored by Oregon Health And Science University, explained in plain language.
-
Finger-Prick test could speed up hepatitis c treatment
Disease control OngoingThis study tests whether using a dried blood spot test (a simple finger prick) can help people with hepatitis C start treatment faster than the usual method that requires a blood draw. The trial involves 141 participants who work with a peer support program and telemedicine. The …
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Hope for Hard-to-Treat lung infection: old drug shows promise
Disease control OngoingThis study tests a drug called clofazimine for people with a chronic lung infection caused by Mycobacterium avium complex (MAC). The goal is to see if adding clofazimine to standard treatment helps clear the bacteria from sputum and improves walking ability and fatigue. About 102…
Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New app helps patients and doctors team up to lower blood pressure
Disease control OngoingThis study tests a new app called COACH that helps patients and their doctors work together to control high blood pressure. The app connects home blood pressure readings to the patient's medical record and sends reminders based on behavioral science. About 550 adults with high bl…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can rewards for personal goals reduce meth overdoses?
Disease control OngoingThis study tests whether offering incentives for achieving self-identified harm reduction goals (like completing overdose prevention training or setting daily life goals) can reduce overdose and increase treatment engagement among people who use methamphetamine. Over 1,200 partic…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Bathroom breakthrough: new wash may stop UTIs in older women
Prevention OngoingThis study tests whether using a chlorhexidine rinse after bowel movements can reduce urinary tract infections (UTIs) in post-menopausal women who already use vaginal estrogen and have frequent UTIs. About 136 women aged 55-89 will be randomly assigned to use either the chlorhexi…
Phase: PHASE4 • Sponsor: Oregon Health and Science University • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
New bus drivers get a boost: study aims to prevent weight gain on the job
Prevention OngoingThis study tests a program to help new bus operators avoid gaining weight and succeed at work. About 284 new hires from several transit agencies will take part. Some will get the special program, while others follow usual routines. The goal is to see if the program helps them sta…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Prevention
Last updated Jun 27, 2026 08:00 UTC
-
Phone program aims to ease chronic pain for rural veterans
Symptom relief OngoingThis Phase 3 trial tests whether a nurse-led phone program can help rural veterans better manage chronic pain. Over 600 participants will receive either the program or a one-time education session, and researchers will track pain interference for 12 months. The goal is to improve…
Phase: PHASE3 • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New study tests peer support to ease transgender surgery journey
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether virtual group support from peers who have had vaginoplasty can help transgender and non-binary people feel more prepared and less stressed before surgery. About 290 adults will be randomly assigned to either the peer support group or standard care with…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New program aims to ease chronic pain for those who care for others
Symptom relief OngoingThis study tests a program called COMPASS-NP for home care workers who have chronic pain. The program combines pain education, coping strategies, and safety tips, led by a trained peer. About 140 workers will take part to see if it reduces how much pain interferes with their work…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New exercise program aims to reduce falls in Parkinson's
Symptom relief OngoingThis study tests a special exercise program called TURN-IT for people with Parkinson's disease who have fallen in the past year. The program focuses on improving turning ability through targeted exercises. 55 participants will either do the program or continue usual care, and res…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Gel or stitches? new study aims to help kids swallow safely
Symptom relief ENROLLING_BY_INVITATIONThis study looks at two different procedures to help children aged 1 to 10 years who have trouble swallowing due to a laryngeal cleft (a gap in the airway). One procedure injects a gel to build up the airway wall, the other uses stitches to close the gap. The goal is to see which…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Body clock study reveals hidden heart risks in obesity
Knowledge-focused OngoingThis study looks at how the body's internal clock (circadian rhythm) affects heart disease risk, especially in people with obesity. Researchers measured blood pressure and other heart markers in 17 lean and overweight adults over 5 days. The goal is to understand if obesity creat…
Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Can rheumatic patients safely get multiple vaccines at once? new study investigates
Knowledge-focused OngoingThis study looks at how well COVID-19 booster vaccines work in people with rheumatic diseases (like arthritis) who take medications that affect their immune system. Researchers want to see if getting the COVID-19 booster at the same time as other routine vaccines (like tetanus or…
Phase: PHASE4 • Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Ashwagandha pill study for seniors pulled before starting
Knowledge-focused TerminatedThis study was designed to see how well compounds from a standardized ashwagandha supplement are absorbed in healthy adults aged 65 and older. Researchers planned to measure levels of active ingredients in the blood after taking the supplement. The study was withdrawn before enro…
Phase: EARLY_PHASE1 • Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Could a simple questionnaire spot sleep apnea in kids with down syndrome?
Knowledge-focused OngoingThis study checks whether sleep questionnaires can reliably detect obstructive sleep apnea (OSA) in children with Down syndrome, who are at higher risk for the condition. Researchers will compare questionnaire results with overnight sleep studies (the gold standard) in about 81 c…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New eye scan could replace dye injections for diabetic retinopathy
Knowledge-focused OngoingThis study is testing whether a special type of eye scan called functional OCT can detect early blood vessel damage in people with diabetic retinopathy. Currently, doctors use a dye injection to see these changes, which can cause side effects. The study will enroll 165 people wit…
Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:15 UTC
-
New eye scan could replace dye tests for Diabetes-Related vision loss
Knowledge-focused OngoingThis study tests a new type of eye scan called OCT angiography (OCTA) to see if it can better measure damage from diabetic retinopathy, a leading cause of vision loss. Researchers will compare OCTA images to standard dye-based tests in 290 people with diabetes. The goal is to fin…
Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:41 UTC